Stage IV Colorectal Cancer Patients with High Risk Mutation Profiles Survived 16 Months Longer with Individualized Therapies

Stage IV Colorectal Cancer Patients with High Risk Mutation Profiles Survived 16 Months Longer with Individualized Therapies

Personalized treatment vs. standard of care is much debated, especially in clinical practice. Here we investigated whether overall survival differences in metastatic colorectal cancer patients are explained by tumor mutation profiles or by treatment differences in real clinical practice. Our retrosp...

Full description

Bibliographic Details
Main Authors: Alexander Hendricks, Anu Amallraja, Tobias Meißner, Peter Forster, Philip Rosenstiel, Greta Burmeister, Clemens Schafmayer, Andre Franke, Sebastian Hinz, Michael Forster, Casey B. Williams
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Cancers
Subjects:
metastatic colorectal cancer
mutational landscape
treatment
overall survival
Online Access:https://www.mdpi.com/2072-6694/12/2/393

Internet

https://www.mdpi.com/2072-6694/12/2/393

Similar Items